Albany International Corp.
NYSE:AINApparel - Manufacturers
+$0.81 today
- Market cap
- $1.86B
- Beta
- 1.21
- P/E (TTM)
- -33.9
- EPS (TTM)
- -$2.10
- Dividend yield
- 1.56%
Volume 0.20M
Average 0.25M
AIN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Albany International Corp.NYSE: AIN
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows in line with its trailing trend
Q1 FY2026 research & development of $12.96M rose 8.9% year over year, ahead of the +8.3% change in trailing-twelve-month research & development. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at +6.3% a year.
Context
- Research & development amounted to 4.1% of revenue in FY2025, up 0.3 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +8.9% holds above the trailing-twelve-month pace of +8.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 48.02M USD
- Year-over-year change
- +4.2%
- 4-year CAGR
- +5.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 48.02M | +4.2% |
| FY2024 | 2024-12-31 | 46.1M | +13.5% |
| FY2023 | 2023-12-31 | 40.63M | +1.7% |
| FY2022 | 2022-12-31 | 39.94M | +2.6% |
| FY2021 | 2021-12-31 | 38.92M | — |
Research & Development vs competitors
How AIN compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +8.3% is the highest of 4, against a peer median of -57.3%.
- Research & development amounts to 4.1% of revenue for AIN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $50M USD | -57.3% | — | 2.7% | |
| LTM Mar 2026 | $49.08M USD | +8.3% | +6.3% | 4.1% | |
| LTM Jun 2025 | $46.27M USD | -53.4% | -23.1% | 1.8% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Oct 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding AIN) | — | -57.3% | -23.1% | 0.0% | |
Competitors are the stored peer set for AIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 929.24M | 1.03B | 1.15B | 1.23B | 1.18B |
| Cost of Revenue | 550.85M | 645.11M | 724.19M | 828.84M | 938.89M |
| Gross Profit | 378.39M | 389.78M | 423.72M | 401.78M | 243.92M |
| Gross Margin | 40.7% | 37.7% | 36.9% | 32.6% | 20.6% |
| Research & Development | 38.92M | 39.94M | 40.63M | 46.1M | 48.02M |
| Selling, General & Admin | 160.13M | 168.71M | 214.92M | 210.88M | 212.07M |
| Operating Expenses | 200.38M | 208.76M | 255.82M | 270.42M | 260.09M |
| Depreciation & Amortization | 74.26M | 69.05M | 76.73M | 89.29M | 87.91M |
| EBITDA | 257.58M | 218.86M | 257.36M | 223M | 52.16M |
| EBITDA Margin | 27.7% | 21.1% | 22.4% | 18.1% | 4.4% |
| Operating Income | 178.01M | 181.02M | 167.89M | 131.36M | (16.17M) |
| Operating Margin | 19.2% | 17.5% | 14.6% | 10.7% | -1.4% |
| Interest Income | 2.5M | 3.84M | 6.57M | 4.06M | 5.16M |
| Interest Expense | 10.91M | 17.68M | 35.41M | 30.39M | 26.03M |
| Other Income / Expenses | (12.08M) | (49.04M) | (7.44M) | (14.27M) | (45.62M) |
| Income Before Tax | 165.93M | 131.98M | 160.46M | 117.09M | (61.79M) |
| Pre-Tax Margin | 17.9% | 12.8% | 14.0% | 9.5% | -5.2% |
| Income Tax Expense | 47.16M | 35.47M | 48.85M | 29.03M | (4.83M) |
| Net Income | 118.48M | 95.76M | 111.12M | 87.62M | (57.34M) |
| Net Margin | 12.7% | 9.3% | 9.7% | 7.1% | -4.8% |
| EPS (Basic) | 3.66 | 3.06 | 3.56 | 2.81 | (1.94) |
| EPS (Diluted) | 3.65 | 3.04 | 3.55 | 2.80 | (1.94) |
| Weighted Avg Shares | 32.35M | 31.34M | 31.17M | 31.23M | 29.57M |
| Weighted Avg Shares (Diluted) | 32.46M | 31.46M | 31.28M | 31.34M | 29.57M |
Albany International Corp.
NYSE:AIN
Intrinsic Alpha fair value
Locked
Current Price
$65.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.